Jun. 3 at 10:41 PM
$GME —
$17 to
$500 on raw retail momentum
$AMC —
$2 to
$70+ fueled by crowd euphoria
$KOSS —
$3 to
$127 in a historic squeeze
$PLTR —
$6 to
$130+ riding government AI hype
But the one setting up now… is 🚨GLMD.🚨
📉 Micro float, huge upcoming catalysts with a bottomed chart
💰
$6.83 cash per share
🚫 No dilution
🔥 FDA fast track + GLP-1 obesity + oncology
📈 Already ran to
$24 before and now it’s even more primed
This isn’t just another biotech it’s the most asymmetric setup in the market.
GLMD could make all of these look small.